These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 640035)

  • 21. Analysis of corticosteroid creams and ointments by high pressure liquid chromatography.
    Mollica JA; Strusz RF
    J Pharm Sci; 1972 Mar; 61(3):444-7. PubMed ID: 5013384
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ophthalmological applications of hydrocortisone ointment].
    Polos'iants OB
    Klin Med (Mosk); 1999; 77(11):40-1. PubMed ID: 10635632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of certain dermatoses with hydrocortisone and prednisolone ointments].
    Dobrotvorskiĭ AE; Demidova NM
    Vestn Dermatol Venerol; 1974; 48(7):74-6. PubMed ID: 4607649
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
    Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
    Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of urea and lactic acid on the percutaneous absorption of hydrocortisone.
    Wahlberg JE; Swanbeck G
    Acta Derm Venereol; 1973; 53(3):207-10. PubMed ID: 4124013
    [No Abstract]   [Full Text] [Related]  

  • 26. Ophthalmic ointments.
    Robin JS; Ellis PP
    Surv Ophthalmol; 1978; 22(5):335-40. PubMed ID: 653578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In-virto determination of parameters influencing the diffusion of hydrocortisone from dermopharaceutic preparations].
    Gillet-Vanderbruggen M; Roland M
    J Pharm Belg; 1975; 30(1):3-22. PubMed ID: 1151605
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical therapy for perioral dermatitis.
    Bikowski JB
    Cutis; 1983 Jun; 31(6):678-82. PubMed ID: 6861520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spectrophotometric determination of sulfapyridazine and sulfadimethoxine in tablets].
    Chichiro VE; Semeĭkina LA
    Farmatsiia; 1970; 19(4):43-5. PubMed ID: 5488019
    [No Abstract]   [Full Text] [Related]  

  • 30. Absorption of topically applied hydrocortisone from the eye of the rhesus monkey.
    Ohman L; Edqvist LE; Johansson ED
    Acta Ophthalmol (Copenh); 1982 Feb; 60(1):106-12. PubMed ID: 7136521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topically administered corticosteroids and treatment of inflammatory keratitis.
    Leibowitz HM; Kupferman A
    Invest Ophthalmol; 1975 May; 14(5):337-40. PubMed ID: 1126821
    [No Abstract]   [Full Text] [Related]  

  • 32. Chlorquinaldol ("Steroxin") with hydrocortisone in the therapy of common dermatoses.
    Rosanove R
    Med J Aust; 1966 Jan; 1(2):54-5. PubMed ID: 5902021
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the use of corticosteroid ointments in dermatology].
    Ciecierski L; Suchanek J
    Przegl Dermatol; 1967; 54(6):703-6. PubMed ID: 6079219
    [No Abstract]   [Full Text] [Related]  

  • 34. [Absorption of corticoid ointments].
    Winkler K
    Ann Dermatol Syphiligr (Paris); 1966; 93(3):265-70. PubMed ID: 5963643
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of prenacide magnetophoresis in complex treatment of some ocular diseases].
    Alekseev BN; Tikhomirova TV
    Vestn Oftalmol; 2003; 119(5):47-8. PubMed ID: 14598498
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
    Heite HJ; Etspüler J
    Arzneimittelforschung; 1977; 27(11a):2234-5. PubMed ID: 580035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
    Yanagawa A; Mizushima Y; Komatsu A; Horiuchi M; Shirasawa E; Igarashi R
    J Microencapsul; 1987; 4(4):329-31. PubMed ID: 3504514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 39. CORTICOSTEROID EYE-DROPS.
    HEWSON GE
    Br Med J; 1964 Feb; 1(5380):438. PubMed ID: 14085977
    [No Abstract]   [Full Text] [Related]  

  • 40. Correct administration of topical eye treatment.
    Marsden J; Shaw M
    Nurs Stand; 2003 Apr; 17(30):42-4. PubMed ID: 12715620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.